Related Experiment Video
Updated: May 13, 2026

E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Healthcare seeking behavior among subjects with irritable bowel syndrome
1Psychiatry Department, Psychosomatic Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia. yrsh@ksu.edu.sa
Abstract:
The behaviors exhibited by individuals who seek healthcare for irritable bowel syndrome (IBS) are numerous, varied, and sometimes controversial, and/or inconsistent. This study aims to review the factors associated with these healthcare seeking behaviors. Through a selective review of the literature, articles were identified by using the following search terms: IBS, healthcare seeking, conventional and non-conventional treatment, cultural factors, and gender differences. The roles of different factors associated with healthcare seeking are discussed.
Related Concept Videos
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome III: Medical and Nursing Management
Irritable Bowel Syndrome
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...